Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Prostatic Neoplasms × fludarabine × Clear all

Phase

Status

Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Recurrence 12 Leukemia, Myeloid, Acute 12 Lymphoma, B-Cell 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Multiple Myeloma 9 Ovarian Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Burkitt Lymphoma 7 Lymphoma, Non-Hodgkin 6 Melanoma 5 Lymphoma, Mantle-Cell 5 Lymphoma 5 Nasopharyngeal Carcinoma 4 Lymphoma, T-Cell 4 Leukemia 3 Hematologic Neoplasms 3 Sarcoma, Synovial 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Myelodysplastic Syndromes 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, T-Cell 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 Graft vs Host Disease 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2

Interventions

Docetaxel 18 Radiosurgery 17 Radiotherapy 14 Androgen Antagonists 14 Leuprolide 11 bicalutamide 9 Goserelin 9 enzalutamide 8 Surveys and Questionnaires 8 Radiotherapy, Intensity-Modulated 7 Prednisone 7 Blood Specimen Collection 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Gonadotropin-Releasing Hormone 6 Triptorelin Pamoate 5 Multiparametric Magnetic Resonance Imaging 5 Brachytherapy 5 Abiraterone Acetate 5 Standard of Care 4 Positron Emission Tomography Computed Tomography 4 Metformin 4 Heavy Ion Radiotherapy 4 Exercise 4 Estramustine 4 pembrolizumab 3 luprolide acetate gel depot 3 darolutamide 3 cabazitaxel 3 abiraterone 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00625430 2011-07-11

FP253-GDEPT

Biotech Equity Partners Pty Ltd

Phase 1 Unknown

Adenoviridae Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡